Aug 17 (Reuters) – US drug developer Novavax Inc said on Monday that it is launching a mid-term study of its experimental COVID-19 vaccine in South Africa as the country experiences an increase in coronavirus cases. The Phase 2b trial of NVX-CoV2373 will be performed on approximately 2,665 healthy adults …
Read More »Novavax begins mid-stage study of COVID-19 vaccine in South Africa
